COVID-19 has challenged us to look at new ways of manufacturing. Just-in-time and lean production has exposed the fragility of our supply chains during the global pandemic. We discuss what has changed, and what will change post-COVID-19.
The pharmaceutical industry is evolving to embrace Industry 4.0 technologies in an effort to modify approaches to drug development and manufacturing. SmartX is Innopharma Technology’s Industry 4.0 platform, designed to accelerate process development and to automate process control in the Pharmaceutical and related manufacturing industries.
The desire for newer, safer, more vibrant and effective cosmetic products led to millennia of technological advancements. We investigate the complexity of modern cosmetics manufacturing and the need for controlling particle size distribution for product quality and safety.
SmartX is among a new wave of software suites to come to market that defies definition under traditional industrial automation nomenclature. Here is how this Pharma-focused Industry 4.0 platform is adding more value to process development and manufacturing activities.
The dawn of the 4th industrial revolution is upon us. SmartX, our Industry 4.0 system, allows connections with a vast array of sensor and process equipment, irrespective of brand and build.
SmartX - Accelerated development and advanced manufacturing platform for Fluid Bed Systems
Eyecon2 - Market-leading particle analyser for powders and bulk solids.
Multieye2 - Multipoint, near infrared spectrophotometer for measuring changes in process.